Since dementia is uncommon in patients with PART [7], the finding of p-MAPT-related axonal damage in the fornix highlights the potential importance of in vivo Aβ imaging and biomarkers to differentiate patients with AD who are more likely to progress to dementia. The gene discussed is MAPT; the disease is Alzheimer disease.